Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ALZN Alzamend Neuro > Detailed Quotes

ALZN Alzamend Neuro

1.1900.0000.00%
Close 09/30 16:00 ET
1.140
-0.050-4.20%
Post Mkt Price 09/30 17:44 ET
High
1.250
Open
1.210
Turnover
842.35K
Low
1.130
Pre Close
1.190
Volume
700.74K
Market Cap
113.62M
P/E(TTM)
Loss
52wk High
3.380
Shares
95.48M
P/E(Static)
Loss
52wk Low
0.801
Float Cap
73.21M
Bid/Ask %
-52.94%
Historical High
33.550
Shs Float
61.52M
Volume Ratio
0.47
Historical Low
0.801
Dividend TTM
--
Div Yield TTM
--
P/B
10.17
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.14%
Amplitude
10.08%
Avg Price
1.202
Lot Size
1
Float Cap
73.21M
Bid/Ask %
-52.94%
Historical High
33.550
Shs Float
61.52M
Volume Ratio
0.47
Historical Low
0.801
Dividend TTM
--
P/B
10.17
Dividend LFY
--
Turnover Ratio
1.14%
Amplitude
10.08%
Avg Price
1.202
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Alzamend Neuro, Inc. is a preclinical stage biopharmaceutical company, which engages in the manufacture of pharmaceutical products. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders. The company was founded on February 26, 2016 by Milton C. Ault, III and is headquartered in Atlanta, GA.
CEO: Mr. Stephan Jackman
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...